Companies: 10,795·Total market cap: $144.5T
Lipella Pharmaceuticals Inc.

Lipella Pharmaceuticals Inc.

LIPOOTCHealthcare● Active
$0.10
$-0.01(-4.76%)
Market Cap$462084
P/E Ratio—
52W High$3.17
52W Low$0.02
Overview

Lipella Pharmaceuticals Inc. (LIPO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · LIPO · as of Mar 28, 2025

Latest filing snapshot

5
+0+0.00%vs prior year

Lipella Pharmaceuticals Inc. (LIPO) employee data is sourced from the annual SEC 10-K filing. As of 2024, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2024-12-31·Full-time · Global
Total Employees
5
Change (1Y)
+0
Growth % (1Y)
+0.00%
Revenue / Employee
$107.3K
Net Income / Employee
$-1.00M
Market Cap
$0M

LIPO Employee Count

2022 – 2024 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2025-03-285+0+0.00%
2024-02-275+0+0.00%
2023-03-315——

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
NKGen Biotech, Inc. Common Stock
NKGN
NKGen Biotech, Inc. Common Stock
63#2
Azitra, Inc.
AZTR
Azitra, Inc.
12#3
Dermata Therapeutics, Inc.
DRMA
Dermata Therapeutics, Inc.
8#4
Indaptus Therapeutics, Inc.
INDP
Indaptus Therapeutics, Inc.
7#5
Artelo Biosciences, Inc.
ARTL
Artelo Biosciences, Inc.
6#6
Lipella Pharmaceuticals Inc.
LIPO
Lipella Pharmaceuticals Inc.YOU
5#7
GT Biopharma, Inc.
GTBP
GT Biopharma, Inc.
1
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · LIPO peer comparison

About LIPO employees

LIPO Employees · Headcount

Lipella Pharmaceuticals Inc. (LIPO) employee data is sourced from the annual SEC 10-K filing. As of 2024, Lipella Pharmaceuticals Inc. had 5 full-time employees globally. Full-time employees only. Global consolidated headcount.

Lipella Pharmaceuticals Inc. employs 5 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $107,271, reflecting the company's operational efficiency.

Lipella Pharmaceuticals Inc.'s workforce increased by 0 (0.00%) in 2024 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Lipella Pharmaceuticals Inc.'s revenue per employee of $107,271 positions it among the notable performers in the Biotechnology sector for operational efficiency.

RevenueFinancial statementsNet incomeSEC filingsPrice historyForecast & ratingsOwnershipEarnings

Frequently Asked Questions

LIPO Employees · 5 questions

As of the latest SEC 10-K filing (2024), Lipella Pharmaceuticals Inc. had 5 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Lipella Pharmaceuticals Inc. employee counthow many employees does Lipella Pharmaceuticals Inc. haveLIPO total employees 2024

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2025-03-28